A

Assure Tech Hangzhou Co Ltd
SSE:688075

Watchlist Manager
Assure Tech Hangzhou Co Ltd
SSE:688075
Watchlist
Price: 37.78 CNY -1.1% Market Closed
Market Cap: ¥4.8B

EV/EBIT

-55.8
Current
89%
More Expensive
vs 3-y average of -29.5

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-55.8
=
Enterprise Value
¥5B
/
EBIT
¥-86.1m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-55.8
=
Enterprise Value
¥5B
/
EBIT
¥-86.1m

Valuation Scenarios

Assure Tech Hangzhou Co Ltd is trading above its 5-year average

If EV/EBIT returns to its 5-Year Average (1.1), the stock would be worth ¥-0.76 (102% downside from current price).

Statistics
Positive Scenarios
0/3
Maximum Downside
-153%
Maximum Upside
No Upside Scenarios
Average Downside
136%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple -55.8 ¥37.78
0%
5-Year Average 1.1 ¥-0.76
-102%
Industry Average 29.4 ¥-19.93
-153%
Country Average 28.9 ¥-19.59
-152%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
CN
Assure Tech Hangzhou Co Ltd
SSE:688075
4.8B CNY -55.8 39.7
US
Medline Inc
NASDAQ:MDLN
60.7B USD 0 0
JP
Hoya Corp
TSE:7741
9.7T JPY 33.6 38.6
CH
Alcon AG
SIX:ALC
29.2B CHF 28 37.3
DK
Coloplast A/S
CSE:COLO B
94.7B DKK 14.9 23.5
US
Align Technology Inc
NASDAQ:ALGN
13.6B USD 19.9 33.2
UK
ConvaTec Group PLC
LSE:CTEC
4.4B GBP 17.8 32.4
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 54.4 -15.5
JP
Asahi Intecc Co Ltd
TSE:7747
890.2B JPY 32.4 50.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
36.7B CNY 20.9 23.3
KR
HLB Inc
KOSDAQ:028300
7.9T KRW -76.3 -36
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
A
Assure Tech Hangzhou Co Ltd
SSE:688075
Average EV/EBIT: 27.7
Negative Multiple: -55.8
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
18%
N/A
JP
Hoya Corp
TSE:7741
33.6
N/A N/A
CH
Alcon AG
SIX:ALC
28
26%
1.1
DK
Coloplast A/S
CSE:COLO B
14.9
7%
2.1
US
Align Technology Inc
NASDAQ:ALGN
19.9
21%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
17.8
21%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
54.4
72%
0.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
32.4
N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
20.9
10%
2.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -76.3 N/A N/A
P/E Multiple
Earnings Growth PEG
CN
A
Assure Tech Hangzhou Co Ltd
SSE:688075
Average P/E: 34.8
39.7
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
38.6
15%
2.6
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.5
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
33.2
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
32.4
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.5 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.3
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
9%
2.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36 N/A N/A

Market Distribution

Lower than 100% of companies in China
Percentile
0th
Based on 5 337 companies
0th percentile
-55.8
Low
0 — 16.6
Typical Range
16.6 — 52.9
High
52.9 —
Distribution Statistics
China
Min 0
30th Percentile 16.6
Median 28.9
70th Percentile 52.9
Max 49 021

Assure Tech Hangzhou Co Ltd
Glance View

Market Cap
4.8B CNY
Industry
Health Care

Assure Tech (Hangzhou) Co., Ltd. engages in the research, development, production, and sale of point-of-care testing (POCT) reagents and instruments. The company is headquartered in Hangzhou, Zhejiang and currently employs 603 full-time employees. The company went IPO on 2021-11-18. The firm's products include antigen and antibody raw materials, immunochromatographic reagents and testing equipment, and dry biochemical reagents and testing equipment. The firm's POCT products cover eight areas of drug testing, infectious disease testing, chronic disease testing, pregnancy testing, tumor testing, myocardial testing, biochemical testing, and allergen testing. The firm's products are sold to the United States, Germany, Britain, Canada and other countries.

Intrinsic Value
62.75 CNY
Undervaluation 40%
Intrinsic Value
Price ¥37.78
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett